Nuwellis Inc
For the period ended Dec 31, 2024. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 11, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: March 11, 2025 | NUWELLIS, INC. | |
|---|---|---|
| By: | /S/ JOHN L. ERB | |
| John L. Erb | ||
| Interim President, Chief Executive Officer and Chairman of the Board | ||
POWER OF ATTORNEY
Each individual person whose signature appears below hereby appoints John L. Erb and Robert Scott as attorneys-in-fact with full power of substitution, severally, to execute in the name and on behalf of each such person, individually and in each capacity stated below, one or more amendments to this annual report which amendments may make such changes in the report as the attorney-in-fact acting in the premises deems appropriate, to file any such amendment to the report with the SEC, and to take all other actions either of them deem necessary or advisable to enable the Company to comply with the rules, regulations and requirements of the SEC.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /S/ JOHN L. ERB | Interim President, Chief Executive Officer and Chairman of the Board | March 11, 2025 |
| John L. Erb | (principal executive officer) | |
| /S/ ROBERT SCOTT | Chief Financial Officer | March 11, 2025 |
| Robert Scott | (principal financial and accounting officer) | |
| /S/ MARIA ROSA COSTANZO, M.D. | Director | March 11, 2025 |
| Maria Rosa Costanzo, M.D. | ||
| /S/ DAVE McDONALD | Director | March 11, 2025 |
| David McDonald | ||
| /S/ GREGORY D. WALLER | Director | March 11, 2025 |
| Gregory D. Waller | ||
| /S/ MIKE McCORMICK | Director | March 11, 2025 |
| Mike McCormick | ||
| /S/ ARCHELLE GEORGIOU, M.D. | Director | March 11, 2025 |
| Archelle Georgiou, M.D. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.